Back to User profile » Dr Taro Kishi
Papers published by Dr Taro Kishi:
Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Naïve Major Depression: A Source-Based Morphometry Study
Okamoto N, Watanabe K, Ngyuyen LH, Ikenouchi A, Kishi T, Iwata N, Kakeda S, Korogi Y, Yoshimura R
Neuropsychiatric Disease and Treatment 2020, 16:2569-2577
Published Date: 29 October 2020
Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolites
Yoshimura R, Kishi T, Iwata N
Neuropsychiatric Disease and Treatment 2019, 15:2655-2661
Published Date: 13 September 2019
A single-nucleotide polymorphism influences brain morphology in drug-naïve patients with major depressive disorder
Katsuki A, Kakeda S, Watanabe K, Igata R, Otsuka Y, Kishi T, Nguyen L, Ueda I, Iwata N, Korogi Y, Yoshimura R
Neuropsychiatric Disease and Treatment 2019, 15:2425-2432
Published Date: 23 August 2019
COMT polymorphism regulates the hippocampal subfield volumes in first-episode, drug-naive patients with major depressive disorder
Otsuka Y, Kakeda S, Sugimoto K, Katsuki A, Nguyen LH, Igata R, Watanabe K, Ueda I, Kishi T, Iwata N, Korogi Y, Yoshimura R
Neuropsychiatric Disease and Treatment 2019, 15:1537-1545
Published Date: 6 June 2019
Melatonin receptor agonists—ramelteon and melatonin—for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials
Kishi T, Nomura I, Sakuma K, Kitajima T, Mishima K, Iwata N
Neuropsychiatric Disease and Treatment 2019, 15:1479-1486
Published Date: 30 May 2019
Genetic effects on white matter integrity in drug-naive patients with major depressive disorder: a diffusion tensor imaging study of 17 genetic loci associated with depressive symptoms
Kakeda S, Watanabe K, Katsuki A, Sugimoto K, Ueda I, Igata N, Kishi T, Iwata N, Abe O, Yoshimura R, Korogi Y
Neuropsychiatric Disease and Treatment 2019, 15:375-383
Published Date: 29 January 2019
Memantine treatment for Japanese patients with moderate to severe Alzheimer’s disease: a meta-analysis of double-blind, randomized, placebo-controlled trials
Kishi T, Matsunaga S, Iwata N
Neuropsychiatric Disease and Treatment 2018, 14:2915-2922
Published Date: 30 October 2018
Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials
Kishi T, Oya K, Matsui Y, Nomura I, Sakuma K, Okuya M, Matsuda Y, Fujita K, Funahashi T, Yoshimura R, Iwata N
Neuropsychiatric Disease and Treatment 2018, 14:2519-2530
Published Date: 1 October 2018
The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis
Kishi T, Matsunaga S, Iwata N
Neuropsychiatric Disease and Treatment 2017, 13:1909-1928
Published Date: 20 July 2017
Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population
Kishi T, Ikuta T, Matsunaga S, Matsuda Y, Oya K, Iwata N
Neuropsychiatric Disease and Treatment 2017, 13:1281-1302
Published Date: 11 May 2017
Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
Kishi T, Matsuda Y, Matsunaga S, Moriwaki M, Otake Y, Akamatsu K, Okochi T, Hirano S, Funahashi T, Okuda M, Tabuse H, Fujita K, Iwata N
Neuropsychiatric Disease and Treatment 2017, 13:117-125
Published Date: 6 January 2017
Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
Okuyama Y, Oya K, Matsunaga S, Kishi T, Iwata N
Neuropsychiatric Disease and Treatment 2016, 12:3221-3236
Published Date: 15 December 2016
A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders
Kishi T, Matsuda Y, Matsunaga S, Mukai T, Moriwaki M, Tabuse H, Fujita K, Iwata N
Neuropsychiatric Disease and Treatment 2016, 12:3041-3049
Published Date: 28 November 2016
Memantine for the treatment of frontotemporal dementia: a meta-analysis
Kishi T, Matsunaga S, Iwata N
Neuropsychiatric Disease and Treatment 2015, 11:2883-2885
Published Date: 12 November 2015
Efficacy and tolerability of aripiprazole once monthly for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
Oya K, Kishi T, Iwata N
Neuropsychiatric Disease and Treatment 2015, 11:2299-2307
Published Date: 3 September 2015
Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials
Kishi T, Matsuda Y, Matsunaga S, Iwata N
Neuropsychiatric Disease and Treatment 2015, 11:419-434
Published Date: 20 February 2015
Iminodibenzyl class antipsychotics for schizophrenia: a systematic review and meta-analysis of carpipramine, clocapramine, and mosapramine
Kishi T, Matsunaga S, Matsuda Y, Iwata N
Neuropsychiatric Disease and Treatment 2014, 10:2339-2351
Published Date: 10 December 2014
Early prediction of blonanserin response in Japanese patients with schizophrenia
Kishi T, Matsuda Y, Fujita K, Iwata N
Neuropsychiatric Disease and Treatment 2014, 10:1861-1866
Published Date: 23 September 2014
COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study
Hayashi K, Yoshimura R, Kakeda S, Kishi T, Abe O, Umene-Nakano W, Katsuki A, Hori H, Ikenouchi-Sugita A, Watanabe K, Ide S, Ueda I, Moriya J, Iwata N, Korogi Y, Kubicki M, Nakamura J
Neuropsychiatric Disease and Treatment 2014, 10:1183-1190
Published Date: 25 June 2014
Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia
Zhao Y, Kishi T, Iwata N, Ikeda M
Neuropsychiatric Disease and Treatment 2013, 9:1655-1659
Published Date: 29 October 2013
Comparative clinical profile of mirtazapine and duloxetine in practical clinical settings in Japan: a 4-week open-label, parallel-group study of major depressive disorder
Nagao K, Kishi T, Moriwaki M, Fujita K, Hirano S, Yamanouchi Y, Funahashi T, Iwata N
Neuropsychiatric Disease and Treatment 2013, 9:781-786
Published Date: 5 June 2013